Parasite Clearance Time and Time to Recurrent Infection Following Treatment With Artemether/Lumefantrine
Status:
Completed
Trial end date:
2012-07-01
Target enrollment:
Participant gender:
Summary
Plasmodium falciparum resistance against artemisinins has been confirmed in South-East Asia
and it is expressed phenotypically as a slow rate of parasite clearance. Nonetheless, it is
not known whether the problem exist in Tanzania. This study assessed parasite clearance time
and time to recurrent infection following treatment with Artemether/Lumefantrine (AL) among
children with uncomplicated malaria.
Phase:
Phase 4
Details
Lead Sponsor:
Muhimbili University of Health and Allied Sciences
Collaborator:
Karolinska Institutet
Treatments:
Artemether Artemether-lumefantrine combination Artemether, Lumefantrine Drug Combination Artemisinins Lumefantrine